Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
1.020
+0.010 (0.99%)
At close: Apr 2, 2026, 4:00 PM EDT
1.000
-0.020 (-1.96%)
After-hours: Apr 2, 2026, 4:53 PM EDT
Aspire Biopharma Holdings Revenue
In the year 2025, Aspire Biopharma Holdings had annual revenue of $6.20K. Aspire Biopharma Holdings had revenue of $4.26K in the quarter ending December 31, 2025.
Revenue (ttm)
$6.20K
Revenue Growth
n/a
P/S Ratio
826.28
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.20K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionASBP News
- 17 days ago - Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion - Accesswire
- 19 days ago - Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director - Accesswire
- 24 days ago - Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 - Accesswire
- 26 days ago - Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Accesswire
- 4 weeks ago - Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief - Accesswire
- 5 weeks ago - Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship - Accesswire
- 6 weeks ago - Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements - Accesswire
- 6 weeks ago - Aspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record - Accesswire